Industry reports
Editor highlights

Therapeutics and Diagnostics for Womens Disorders

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Signal Management - Medical Device Safety and Approval Report - Comprehensive

Signal Management - Medical Device Safety and Approval Report - Comprehensive

  • $ 99
  • Industry report
  • by DeviceMatters
  • April 2014
  • 56 pages

The comprehensive DeviceMatters medical device safety and approval report provides an overview of Signal Management, recent device approvals, supplements, recalls, and in-depth review of adverse event trends and insights including specific device failure modes. This 626kb pdf report is 56 pages long. ...

Industries: Biomaterial, General Medicine and Specialty Medicine | Countries: United States

Physician Views - Are physicians getting the biosimilar education they need?

Physician Views - Are physicians getting the biosimilar education they need?

  • $ 731
  • Industry report
  • by Firstword Pharma
  • April 2014

Biosimilars remain one of the pharmaceutical industry's hot topics. Branded biologics account for 7 of the 10 best selling drugs globally and significant legislative momentum was provided in 2013 when the European Medicines Agency (EMA) approved its first biosimilar antibody products (versions of the ...

Industries: Biopharmaceutical | Countries: United States

Biomarker Partnering Terms and Agreements

Biomarker Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • by Currentpartnering
  • April 2014
  • 998 pages

The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering deals Biomarker partnering agreement structure Biomarke ...

Industries: Genomics | Countries: United States

North America Orthobiologics Procedures Outlook to 2020

North America Orthobiologics Procedures Outlook to 2020

  • $ 450
  • Industry report
  • by Global Data
  • March 2014
  • 21 pages

North America Orthobiologics Procedures Outlook to 2020 Summary GlobalData's new report, "North America Orthobiologics Procedures Outlook to 2020", provides key procedures data on the North America Orthobiologics (Bone Graft) Procedures. The data in the report is derived from dynamic market forecast ...

Industries: Biomaterial, Blood Supply, Tissue Banking and Transplantation | Countries: North America, United States, Mexico, Canada, World

TriLink BioTechnologies - Pharmaceuticals & Healthcare - Deals and Alliances Profile

TriLink BioTechnologies - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • March 2014
  • 20 pages

Summary TriLink BioTechnologies, Inc. (TriLink) is a biotechnology company. The company manufactures and modifies oligonucleotides and nucleoside triphosphates. Its products include oligonucleotides, nucleotides, polyphosphates, phosphoramidites, DNA synthesis reagents, CleanAmp PCR Pro, RNA transcripts, ...

Industries: Biotechnology | Countries: United States

Accentia Biopharmaceuticals, Inc. (ABPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Accentia Biopharmaceuticals, Inc. (ABPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • March 2014
  • 39 pages

Summary Accentia Biopharmaceuticals, Inc. (Accentia) is a biotechnology company. It identifies, develops and commercializes patent-protected disruptive healthcare technologies for the treatment of chronic and life threatening diseases including the respiratory, autoimmune and cancer indications. The ...

Industries: Biopharmaceutical | Countries: United States

Competitor Analysis: Cancer Vaccines

Competitor Analysis: Cancer Vaccines

  • $ 1 056
  • Industry report
  • by La Merie Publishing
  • March 2014
  • 179 pages

Cancer Vaccines The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of ...

Industries: Biopharmaceutical | Countries: United States

Alcohol and Starch/Sugar Enzyme Market by Type (Carbohydrase, Protease, and Lipase), by Application (Industrial, Specialty) & Geography - Global Trends & Forecasts to 2018

Alcohol and Starch/Sugar Enzyme Market by Type (Carbohydrase, Protease, and Lipase), by Application (Industrial, Specialty) & Geography - Global Trends & Forecasts to 2018

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • March 2014
  • 209 pages

Alcohol enzymes are extensively used in various industrial applications that incorporate the production of food and beverages, biofuels, cleaning agents, and others. Due to their versatile applications, alcohol enzymes are in great demand to suffice the tremendous requirement for industrial products ...

Industries: Biopharmaceutical | Countries: World, France, United States, South Africa, North America, Brazil, Mexico, Canada, Germany, Japan, India, China, Europe, Africa

Stemgent, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Stemgent, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • March 2014
  • 26 pages

Summary Stemgent, Inc. (Stemgent) is a biotechnology company. It focuses on the development of innovative technology and application solutions for the advancement of stem cell research. The company's product portfolio comprises antibodies, cell lines, cytokines / proteins, differentiation, matrices, ...

Industries: Biological Therapy | Countries: United States

Genomic Health, Inc. (GHDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genomic Health, Inc. (GHDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • March 2014
  • 22 pages

Summary Genomic Health, Inc. (Genomic Health) is a life sciences company. It focuses on the research, development and commercialization of genomic-based clinical laboratory services for the treatment of cancer. The company's commercial product portfolio consists of Oncotype DX breast cancer test and ...

Industries: Genomics | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.